Stockscreener 앱 받기
2.69
2.89%
-0.08
시간 외 거래:
2.72
0.03
+1.12%
전일 마감가:
$2.77
열려 있는:
$2.76
하루 거래량:
44,408
Relative Volume:
0.66
시가총액:
$7.75M
수익:
$77,900
순이익/손실:
$-8.05M
주가수익비율:
-0.2915
EPS:
-9.2296
순현금흐름:
$-7.47M
1주 성능:
+12.08%
1개월 성능:
+2.28%
6개월 성능:
+5.91%
1년 성능:
-61.84%
1일 변동 폭
$2.64
$2.76
1주일 범위
$2.36
$2.83
52주 변동 폭
$1.95
$12.03
Aclarion Inc Stock (ACON) Company Profile
명칭
Aclarion Inc
전화
833 275 2266
주소
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, TEM, BTSG, HQY, TXG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.69 | 7.98M | 77,900 | -8.05M | -7.47M | -9.2296 |
VEEV
Veeva Systems Inc
|
250.53 | 40.77B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
66.65 | 11.05B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
59.53 | 11.74B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
104.27 | 8.69B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
63.87 | 8.10B | 638.78M | -22.66M | 122.18M | -0.1744 |
Aclarion Inc 주식(ACON)의 최신 뉴스
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site - orthospinenews.com
Aclarion adds University of Arizona to Nociscan spine trial - Investing.com
Aclarion Announces Addition of University of Arizona College of MedicinePhoenix as CLARITY Trial Site - The Manila Times
Aclarion's 300-patient back-pain study now has 10 enrolling sites - Stock Titan
Aclarion (ACON) EPS and Revenue: The Available Earnings Metric Delivers a Miss in Latest Trading; After Results: The Stock Gains 6.54% on the DayROIC Trend Report - Vinanet
Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Amanda Williams buys $15,989 in common stock - Investing.com
Top Aclarion Executive Makes Bold Insider Move on Company Stock - TipRanks
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com Nigeria
Aclarion (ACON) Earnings Numbers in Focus: EPS Comes in Below Forecast under the Current Snapshot; Investor Response: The Market Price Declines 6.14% on the DayHealthcare Earnings Report - Vinanet
ACON | Aclarion, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock - Investing.com
Major Insider Buying Spree Signals Strong Confidence in This Tech Stock - TipRanks
Aclarion director David K. Neal buys $18,000 in common stock By Investing.com - Investing.com Nigeria
Aclarion director David K. Neal buys $18,000 in common stock - Investing.com
Aclarion CEO Brent Ness buys $12,090 in company stock By Investing.com - Investing.com India
Aclarion director William Wesemann buys $5,031 in company stock - Investing.com
Aclarion director Ryan Bond buys $50,059 in ACON shares - Investing.com
Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeNarrow Range Breakout - dars.gov.et
Aclarion receives patent allowance for MRI scan technology By Investing.com - Investing.com Nigeria
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process - The Manila Times
Aclarion Receives USPTO Notice of Allowance for Patent Covering Multi-Voxel Prescription for Lumbar Disc Evaluation - Quiver Quantitative
Aclarion receives patent allowance for MRI scan technology - Investing.com
Aclarion Receives Notice Of Allowance For Patent Advancing Accuracy And Adoption Of Nociscan's MR Spectroscopy Scan Process - marketscreener.com
Aclarion says USPTO issues notice of allowance for lumbar disc MRS scan-prescription patent application - Bitget
Aclarion Inc. (ACON) Slips 3.39% as Shares Approach Key $2.17 SupportTake Profit Levels - Vinanet
Aclarion, Inc. Revenue Breakdown – FWB:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – BOATS:ACONW - TradingView
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Aclarion, Inc. Q2 2026: Revenue $25.2K, EPS $(1.12) — 10-Q Summary - TradingView
Aclarion (NASDAQ: ACON) posts $5.6M H1 loss, holds $16.3M cash - Stock Titan
Tranche Update on Aclarion, Inc.'s Equity Buyback Plan announced on April 22, 2026. - marketscreener.com
Aclarion Q2 FY26 net loss narrows 59.27% to $2.75 million; revenue rises 30.5% to $25,208 - Bitget
Aclarion Inc. Warrant (ACONW) Slips 2.39% but Remains Supported at $0.02Resistance Breakout Stocks - dars.gov.et
Aclarion (ACON) Slips 1.69% to $2.32: Stock Presses Against Support at $2.20Strong Buy Stocks - dars.gov.et
Aclarion’s Nociscan Expands to Goodman Campbell Brain & Spine in First Indiana Site - Quiver Quantitative
Aclarion, Inc Announces Nociscan Now Available At Goodman Campbell Brain & Spine At Ascension St. Vincent - marketscreener.com
Aclarion Inc. Warrant (ACONW) Surges 35% to $0.03, Trading at Critical JunctureETF Inflow Streak - dars.gov.et
Aclarion Inc. Warrant (ACONW) Holds at $0.02 as Trading Range Compresses to a PointFibonacci Retracement - dars.gov.et
Aclarion Inc. Warrant (ACONW) Holds Steady at $0.02 as Trading Range CompressesReversal Trade - Vinanet
ACON Q1 2026 Earnings: EPS Exceeds Estimates by 15.2%, Shares Rise 11.4%Earnings Deceleration Risk - Vinanet
Aclarion Inc. Warrant (ACONW) Flat at $0.02 as Support and Resistance ConvergePrice Target - Vinanet
Aclarion reports 141% scan volume growth in first half of 2026 - Investing.com Nigeria
Aclarion Inc. (ACON) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SentimentPost-Announcement Reaction - Vinanet
Aclarion, Inc. Revenue Breakdown – BOATS:ACON - TradingView
Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACON) Institutional Confidence - TradingKey
Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aclarion Inc 주식 (ACON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Gould Gregory A | CFO |
Aug 14 '26 |
Buy |
2.45 |
10,000 |
24,500 |
60,000 |
| Bond Ryan | Director |
Aug 13 '26 |
Buy |
2.37 |
21,122 |
50,059 |
76,122 |
| Wesemann William | Director |
Aug 13 '26 |
Buy |
2.34 |
2,150 |
5,031 |
23,713 |
| Neal David K | Director |
Aug 13 '26 |
Buy |
2.40 |
7,500 |
18,000 |
30,002 |
| Ness Brent | Chief Executive Officer |
Aug 13 '26 |
Buy |
2.31 |
5,234 |
12,091 |
111,534 |
| Breidbart Scott | Director |
May 12 '26 |
Buy |
3.18 |
5,664 |
18,012 |
5,664 |
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
1.35%
2.79%
자본화:
|
볼륨(24시간):